Semler Scientific (NASDAQ:SMLR) Trading Down 5.1% – Time to Sell?

Semler Scientific, Inc. (NASDAQ:SMLR) shares were down 5.1% during mid-day trading on Wednesday . The company traded as low as $62.12 and last traded at $61.64. Approximately 53,241 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 387,956 shares. The stock had previously closed at $64.94.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital raised their price objective on Semler Scientific from $40.00 to $71.00 and gave the company a “buy” rating in a research report on Friday.

Semler Scientific Price Performance

The stock’s 50 day simple moving average is $59.91 and its two-hundred day simple moving average is $39.99. The firm has a market cap of $514.11 million, a P/E ratio of 27.05 and a beta of 1.18.

Semler Scientific (NASDAQ:SMLR) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.35. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%. The company had revenue of $13.51 million for the quarter.

Hedge Funds Weigh In On Semler Scientific

Large investors have recently modified their holdings of the stock. Newbridge Financial Services Group Inc. bought a new stake in Semler Scientific during the 2nd quarter valued at about $34,000. Quest Partners LLC increased its position in shares of Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock valued at $59,000 after acquiring an additional 817 shares in the last quarter. US Bancorp DE increased its position in shares of Semler Scientific by 60.8% during the third quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after acquiring an additional 1,158 shares in the last quarter. Sanctuary Advisors LLC purchased a new position in Semler Scientific in the 3rd quarter worth approximately $104,000. Finally, Veery Capital LLC bought a new position in Semler Scientific in the 4th quarter valued at approximately $324,000. Hedge funds and other institutional investors own 49.37% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.